Cargando…

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?

SIMPLE SUMMARY: In the last decade, medulloblastoma entered the molecular era, with progressive advances in the knowledge of the molecular biology of this rare tumor. These expanding data have allowed the recognition of four distinct molecular subgroups, and, subsequently, the design of novel clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Bartolini, Stefania, Brandes, Alba Ariela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773620/ https://www.ncbi.nlm.nih.gov/pubmed/35053495 http://dx.doi.org/10.3390/cancers14020333

Ejemplares similares

Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Tumor-Associated Microenvironment of Adult Gliomas: A Review
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
por: Maggio, Ilaria, et al.
Publicado: (2021)

Glioblastoma: Emerging Treatments and Novel Trial Designs
por: Di Nunno, Vincenzo, et al.
Publicado: (2021)

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology
por: Gatto, Lidia, et al.
Publicado: (2022)

Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution
por: Di Nunno, Vincenzo, et al.
Publicado: (2023)

Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
por: Gatto, Lidia, et al.
Publicado: (2021)

Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19
por: Gatto, Lidia, et al.
Publicado: (2020)

IDH1 Non-Canonical Mutations and Survival in Patients with Glioma
por: Franceschi, Enrico, et al.
Publicado: (2021)

DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open
por: Gatto, Lidia, et al.
Publicado: (2023)

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
por: Maggio, Ilaria, et al.
Publicado: (2021)

Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?
por: Di Nunno, Vincenzo, et al.
Publicado: (2023)

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap
por: Gatto, Lidia, et al.
Publicado: (2023)

Olfactory neuroblastoma: diagnosis, management, and current treatment options
por: Tosoni, Alicia, et al.
Publicado: (2023)

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study
por: Franceschi, E., et al.
Publicado: (2020)

Adult Medulloblastoma: Updates on Current Management and Future Perspectives
por: Franceschi, Enrico, et al.
Publicado: (2022)

miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children
por: Visani, Michela, et al.
Publicado: (2020)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
por: Brandes, Alba A., et al.
Publicado: (2017)

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference
por: Morandi, Luca, et al.
Publicado: (2010)

Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. Diagnostics 2020, 10, 265
por: Visani, Michela, et al.
Publicado: (2021)

Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1(105GGT)) in brain tumors of a cohort of Italian patients
por: Acquaviva, Giorgia, et al.
Publicado: (2018)

ASD–Time for a paradigm shift
por: Levy, Yonata
Publicado: (2022)

Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)

Molecular Docking: Shifting Paradigms in Drug Discovery
por: Pinzi, Luca, et al.
Publicado: (2019)

Molecular Biosimilarity—An AI-Driven Paradigm Shift
por: Niazi, Sarfaraz K.
Publicado: (2022)

Keratoprosthesis prophylaxis: is it time for a paradigm shift?
por: Pelletier, JS, et al.
Publicado: (2018)

Shifting Sugars and Shifting Paradigms
por: Siegal, Mark L.
Publicado: (2015)

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria
por: Lanese, Andrea, et al.
Publicado: (2018)

Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy
por: Brandes, Alba A, et al.
Publicado: (2020)

Rare Primary Central Nervous System Tumors in Adults: An Overview
por: Franceschi, Enrico, et al.
Publicado: (2020)

Is it time for a paradigm shift in understanding embryo selection?
por: Gleicher, Norbert, et al.
Publicado: (2015)

Time for a paradigm shift in the classification of muscle injuries
por: Hamilton, Bruce, et al.
Publicado: (2017)

Large hiatus hernia: time for a paradigm shift?
por: Rajkomar, Kheman, et al.
Publicado: (2022)

A paradigm shift
Publicado: (2009)

Paradigm shift: the Copernican revolution in diverticular disease
por: Zullo, Angelo, et al.
Publicado: (2019)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

Medulloblastoma in the Molecular Era
por: Miranda Kuzan-Fischer, Claudia, et al.
Publicado: (2018)

Allergy as a Disease of Dysbiosis: Is It Time to Shift the Treatment Paradigm?
por: Myles, Ian A.
Publicado: (2019)

Perioperative Care for Organ Transplant Recipient: Time for Paradigm Shift
por: Vitin, Alexander A.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_stdot7ktko25kj6o29baod0pom